Oliver Lagore Vanvalin Investment Group bought a new stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 20,959 shares of the company’s stock, valued at approximately $3,572,000. Procter & Gamble comprises 1.3% of Oliver Lagore Vanvalin Investment Group’s investment portfolio, making the stock its 17th largest holding.
Several other institutional investors have also added to or reduced their stakes in the business. Brighton Jones LLC boosted its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its stake in shares of Procter & Gamble by 493.6% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 341,750 shares of the company’s stock worth $57,294,000 after buying an additional 284,174 shares during the last quarter. Two Sigma Advisers LP boosted its stake in shares of Procter & Gamble by 100.5% in the 4th quarter. Two Sigma Advisers LP now owns 110,300 shares of the company’s stock worth $18,492,000 after buying an additional 55,300 shares during the last quarter. Two Sigma Investments LP boosted its stake in shares of Procter & Gamble by 2.4% in the 4th quarter. Two Sigma Investments LP now owns 18,133 shares of the company’s stock worth $3,040,000 after buying an additional 433 shares during the last quarter. Finally, Voloridge Investment Management LLC boosted its stake in shares of Procter & Gamble by 671.8% in the 4th quarter. Voloridge Investment Management LLC now owns 209,000 shares of the company’s stock worth $35,039,000 after buying an additional 181,921 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
NYSE:PG opened at $157.32 on Friday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business’s 50-day simple moving average is $156.17 and its two-hundred day simple moving average is $161.49. The stock has a market cap of $368.21 billion, a PE ratio of 24.17, a P/E/G ratio of 4.23 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is presently 64.98%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Sundar G. Raman sold 9,554 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer directly owned 41,886 shares of the company’s stock, valued at $6,624,689.76. The trade was a 18.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 8,596 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the sale, the chief executive officer directly owned 64,991 shares in the company, valued at $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 120,181 shares of company stock valued at $18,918,012 over the last ninety days. 0.20% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. Wells Fargo & Company dropped their price target on Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Evercore ISI reiterated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reiterated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Barclays set a $164.00 target price on Procter & Gamble and gave the company an “equal weight” rating in a research report on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $173.94.
View Our Latest Report on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- What is a SEC Filing?
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- 3 REITs to Buy and Hold for the Long Term
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.